Navigation Links
Mosquitoes can't spot a spermless mate
Date:8/8/2011

A female mosquito cannot tell if the male that she has mated with is fertile or 'spermless' and unable to fertilise her eggs, according to a new study from scientists at Imperial College London.

The research, published today in the journal Proceedings of the National Academy of Sciences, could help scientists in their mission to prevent the spread of malaria by interfering with the mosquitoes' ability to reproduce.

Malaria is a debilitating disease that affects more than 300 million people every year, and kills nearly 800,000 annually. In Africa, a child dies of malaria about every 45 seconds. Public health experts are working towards the eradication of malaria, but there is a recognised need for better and lower cost tools to achieve the eradication goal. The new study focuses on Anopheles gambiae, the species of mosquito primarily responsible for the transmission of malaria in Africa.

Today's results lend support to the idea that in the future it will be possible to control the size of the malaria-carrying mosquito population by introducing a genetic change that makes the males sterile. Such a method would rely on females mating unknowingly with such modified males and failing to produce any offspring. Although researchers are currently working on this solution, nothing has yet been trialled.

This study was carried out thanks to funding by the Medical Research Council in the UK and the European Community FP7 Collaborative Project grant called Malbecblok.

Lead author of the study, Dr Flaminia Catteruccia from the Department of Life Sciences at Imperial College London, said: "In the fight against malaria, many hope that the ability to genetically control the mosquito vector will one day be an key part of our armoury. In order for these currently theoretical control strategies to work, we need to make sure that the insects continue to mate as normal, unaware that we have interfered with their sexual m
'/>"/>

Contact: Simon Levey
s.levey@imperial.ac.uk
44-207-594-6702
Imperial College London
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Study shows how mosquitoes handle the heat of a hot blood meal
2. Genetic markers offer new clues about how malaria mosquitoes evade eradication
3. Mother Nature to provide an environmentally friendly method for reducing mosquitoes
4. ARS study provides a better understanding of how mosquitoes find a host
5. New way to control disease-spreading mosquitoes: Make them hold their urine
6. Are sterile mosquitoes the answer to malaria elimination?
7. Midge keeps invasive mosquito in check, aiding native mosquitoes
8. Penn State entomologists seek fungus to blunt mosquitoes sense of smell
9. Mosquitoes create harmonic love song before mating, study finds
10. Lincoln Park Zoo awarded 2 significant grants for science education
11. Mitochondria share an ancestor with SAR11, a globally significant marine microbe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)... , July 9, 2015  Unchained Labs just ... its acquisition of Avid Nano. Avid Nano designs, ... (DLS) systems.    Also today, Unchained ... and easiest to use protein sizing system. The ... a protein,s hydrodynamic size, size distribution, aggregation population ...
(Date:7/8/2015)... YORK , July 8, 2015 Summary ... globally, and the fourth most fatal, with a mortality ... The poor prognosis of pancreatic cancer patients has highlighted ... treatment, which is not being met by the current ... an array of products with varying molecule types and ...
(Date:7/8/2015)... July 8, 2015  Trovagene, Inc. (NASDAQ: ... today announced the launch of a study that ... Cancer Monitoring℠ (PCM) technology for predicting response to ... a combination of the novel immunotherapy agents Yervoy® ... PD-1 inhibitor. The 50-patient study will be led ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... funding of a world-leading suite of software that allows scientists ... total 1.43M of funding has been awarded to eight components ... application process. Seven of the eight projects are ... funding the eighth. CCP4, which has contributors from ...
... have shown natural radioactivity within DNA can alter chemical ... The research, recently published in Biochimica et Biophysica ... natural radioactivity within human DNA on the atomic-scale. ... well as in every living organism across the planet, ...
... Espoo, Finland and Ebersberg, Germany, December 17th, 2013 - ... line of Eurofins Scientific and Orion Diagnostica Oy, an ... and sales of diagnostic test systems, announced that they ... Oy owns the global rights for the SIBA isothermal ...
Cached Biology News:Radioactivity muddles the alphabet of DNA 2
(Date:7/30/2015)... ... July 31, 2015 , ... Ralco is honored to announce that ... County Fair to be held August 5-9 in Marshall. The Ralco Enrichment Center is ... from and how agriculture impacts their daily lives. This unique exhibit also features a ...
(Date:7/30/2015)... According to a new market ... PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), ... by End Users - Global Forecast to 2020", published ... USD 2,107.99 million by 2020 from USD 1,034.93 million ... Browse more than 75 ...
(Date:7/30/2015)... , July 30, 2015 Ascendis Pharma ... that applies its innovative TransCon technology to address ... results from a six-month Phase 2 study to ... Growth Hormone in 53 treatment-naïve, pre-pubertal children with ... are extremely pleased with the top-line results from ...
(Date:7/29/2015)... , July 30, 2015 ... results for the second quarter of 2015. CEO ... results and its performance in different businesses. ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered ... results - Performance drivers ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... ... in prison for murder; guilty man kills again. , ... Rochester, NY (PRWEB) May 5, 2010 -- National Association of ... criminal investigations. A recent WHEC.com story concerns what can only be described as ...
... 4, 2010) Endoscopic radiofrequency ablation is an effective ... a fast and effective way to detect inflammatory bowel ... gastrointestinal tissue that is removed, and researchers find that ... bile duct) is more precise than surgery with fewer ...
... 4 InterMune, Inc. (Nasdaq: ITMN ) today announced that ... for the New Drug Application (NDA) for Esbriet™ (pirfenidone) for the treatment ... function. , , , ... letter is issued by the FDA,s Center for Drug Evaluation and Research ...
Cached Biology Technology:NACVSA Points out Perils of Polygraph: Killer Passes Polygraph, Innocent Man Fails, Killer Goes On To Kill Again 2NACVSA Points out Perils of Polygraph: Killer Passes Polygraph, Innocent Man Fails, Killer Goes On To Kill Again 3NACVSA Points out Perils of Polygraph: Killer Passes Polygraph, Innocent Man Fails, Killer Goes On To Kill Again 4Latest breakthroughs in technology expand options for diagnosing and treating disease 2Latest breakthroughs in technology expand options for diagnosing and treating disease 3Latest breakthroughs in technology expand options for diagnosing and treating disease 4Latest breakthroughs in technology expand options for diagnosing and treating disease 5Latest breakthroughs in technology expand options for diagnosing and treating disease 6Latest breakthroughs in technology expand options for diagnosing and treating disease 7Latest breakthroughs in technology expand options for diagnosing and treating disease 8Latest breakthroughs in technology expand options for diagnosing and treating disease 9Latest breakthroughs in technology expand options for diagnosing and treating disease 10Latest breakthroughs in technology expand options for diagnosing and treating disease 11InterMune Receives FDA Complete Response Letter on Esbriet(TM) (Pirfenidone) New Drug Application 2InterMune Receives FDA Complete Response Letter on Esbriet(TM) (Pirfenidone) New Drug Application 3InterMune Receives FDA Complete Response Letter on Esbriet(TM) (Pirfenidone) New Drug Application 4InterMune Receives FDA Complete Response Letter on Esbriet(TM) (Pirfenidone) New Drug Application 5
PPOX Immunogen: PPOX (AAH02357, 378 a.a. ~ 478 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
KRIT1 Immunogen: KRIT1 (NP_004903, 637 a.a. ~ 737 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rabbit polyclonal to MAP3K12 ( Abpromise for all tested applications). Antigen: Synthetic peptide conjugated to KLH from the C-terminal region of human MAP3K12 Entrez Gene ID: 7786 Swiss ...
Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
Biology Products: